Articles Archives | Page 127 of 128 | Sterne Kessler

Amgen, Sandoz Both Winners and Losers At Federal Circuit

America Invents Act: For US IP, The Cheese Has Been Moved

Amending Claims in Post-Grant Proceedings and Information

Amdocs: An ‘I Know It When I See It’ Test For Abstract Ideas

AIA Post-Grant Trial Proceedings: Three Important Developments to Watch

After Alice: The Two-Step Rule

Acorda Therapeutics v. Mylan Pharmaceuticals: A New Kind of Jurisdiction for ANDA Cases

AbbVie Deutschland and Unknown Embodiments: Has the Written Description Requirement for Antibodies Gone Too Far?

A Means-Plus-Function Looking-Glass into Statutory Subject Matter Post-Alice

5 Ways To Avoid Obviousness-Type Double Patenting